Johnson & Johnson reports data from Phase II prostate cancer trial [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
therapy (ADT) in high-risk localised prostate cancer (HRLPC) patients post-radical prostatectomy (RP). The single-arm, open-label, multicentre study involved 108 subjects enrolled across 32 US community urologic practices. The participants were treatment-naïve individuals with HRLPC who had undergone RP. They received a daily dose of 240mg ERLEADA for 12 cycles, alongside ADT for one year. Assessing the biochemical recurrence (BCR)-free rate was the trial's primary goal. The secondary objectives of the study included assessing the testosterone recovery rate and the safety of the treatment regimen. The findings indicated that the patients who underwent the treatment regimen exhibited a 100% BCR-free rate at the 24-month mark, meeting the primary endpoint. This outcome suggests that the therapy effectively prevents the recurrence of cancer as measured by PSA levels after an additional year of follow-up post-treatment. The study also reported a serum testosterone recovery r
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution [Yahoo! Finance]Yahoo! Finance
- J&J-backed startup Rapport files for US IPO [Yahoo! Finance]Yahoo! Finance
- Medtronic study of Affera Sphere-9 Catheter meets endpoints [Seeking Alpha]Seeking Alpha
- Dow closes above 40,000 for first time, notching new milestone [CBS News]CBS News
- Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/17/24 - Form 8-K
- 5/16/24 - Form 424B2
- 5/15/24 - Form 424B2
- JNJ's page on the SEC website